1. |
Zhou L, Ren R, Yang L, et al. Sudden increase in human infection with avian influenza A(H7N9) virus in China, September-December 2016. Western Pac Surveill Response J, 2017;8(1): 6-14.
|
2. |
Wang X, Jiang H, Wu P, et al. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis, 2017, 17(8): 822-832.
|
3. |
2017 年 2 月全国法定传染病疫情概况. http://www.nhfpc.gov.cn/jkj/s3578/201703/3fed3e04129b49e8a860e47cfe742c63.shtml.
|
4. |
2017 年 3 月全国法定传染病疫情概况.http://www.nhfpc.gov.cn/jkj/s3578/201704/48aa9c141c224444925a883b8d227831.shtml.
|
5. |
2017 年 4 月全国法定传染病疫情概况. http://www.nhfpc.gov.cn/jkj/s3578/201705/5ea6ba8bf31645349f9bb5572b6df9ea.shtml.
|
6. |
2017 年 5 月全国法定传染病疫情概况.http://www.nhfpc.gov.cn/jkj/s3578/201706/99b1482bfd7e499db90b3ee133e56e13.shtml.
|
7. |
2017 年 6 月全国法定传染病疫情概况.http://www.nhfpc.gov.cn/jkj/s3578/201707/003fec8e8b7e449084ad7abd68e9bff6.shtml.
|
8. |
2017 年 7 月全国法定传染病疫情概况. http://www.nhfpc.gov.cn/jkj/s3578/201708/e811ea0e16ed43949bfae0847d4701c9.shtml.
|
9. |
Xiang N, Li X, Ren R, et al. Assessing change in avian influenza A (H7N9) virus infections during the Fourth Epidemic - China, September 2015-August 2016. Morb Mortal Wkly Rep, 2016;65(49): 1390-1394.
|
10. |
Ke C, Mok CKP, Zhu W, et al. Human infection with highly pathogenic avian influenza A(H7N9) virus, China. Emerg Infect Dis, 2017, 23(8): 1332-1340.
|
11. |
Cao B, Gao H, Zhou B, et al. Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia. Crit Care Med, 2016, 44(6): e318-28.
|
12. |
中华人民共和国国家卫生和计划生育委员会. 人感染 H7N9 禽流感诊疗方案(2017 年第一版). 中华临床感染病杂志, 2017, 10(1): 1-4.
|
13. |
Bilan N, Dastranji A, Ghalehgolab Behbahani A. Comparison of the spo2/fio2 ratio and the PaO2/FiO2 ratio in patients with acute lung injury or acute respiratory distress syndrome. J Cardiovasc Thorac Res, 2015, 7(1): 28-31.
|
14. |
Quispe-Laime A, Bracco J, Barberio P, et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med, 2010, 36(1): 33-41.
|
15. |
Diaz E, Martin-Loeches I, Canadell L, et al. Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza.J Infect, 2012, 64(3): 311-318.
|
16. |
Liem N, Tung C, Hien N, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006.Clin Infect Dis, 2009, 48(12): 1639-1646.
|
17. |
Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, et al. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev, 2016, 3: CD010406.
|
18. |
Zhou J, Wang D, Gao R, et al. Biological features of novel avian influenza A (H7N9) virus. Nature, 2013, 499(7459): 500-503.
|
19. |
Chi Y, Zhu Y, Wen T, et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis, 2013, 208(12): 1962-1967.
|
20. |
Bentzer P, Fjell C, Walley KR, et al. Plasma cytokine levels predict response to corticosteroids in septic shock. Intensive Care Med, 2016, 42(12): 1970-1979.
|
21. |
Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med, 2013, 368(24): 2277-2285.
|
22. |
Ma W, Huang H, Chen J, et al. Predictors for fatal human infections with avian H7N9 influenza, evidence from four epidemic waves in Jiangsu Province, Eastern China, 2013-2016. Influenza Other Respir Viruses, 2017, 11(5):418-424.
|
23. |
Zheng S, Wu J, Yu F, et al. Elevation of creatine kinase is linked to disease severity and predicts fatal outcomes in H7N9 infection. Clin Chem Lab Med, 2017, 55(8): e163-e166.
|
24. |
Meduri GU, Bridges L, Shih MC, et al. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med, 2016, 42(5): 829-840.
|
25. |
Sweeney RM, McAuley DF. Acute respiratory distress syndrome. Lancet, 2016, 388(10058): 2416-2430.
|